Authors
Latest:
Q&A: Deepak Sambhara, MD, discusses real-world follow-up for patients with GAA study reveals attrition rates in patients with geographic atrophy on complement inhibitor therapies, highlighting the need for improved treatment adherence strategies.
Latest:
The evolving role of vitreosurgical simulators in surgical trainingNeed to eliminate errors results in optimization of training of novice surgeons.
Latest:
A look at the vorolanib intravitreal insert compared with aflibercept for DMEEYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in vision and safety.
Latest:
Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitisDilraj S. Grewal, MD, FASRS, provides an in-depth overview of the current state of research and treatment innovations.
Latest:
CCS 2025: Patient journey with neovascular retinal disease through advanced treatment and beyondDeep Parikh, MD, sat down with Emily Kaiser Maharjan from Optometry Times to talk about his presentation at Collaborative Care Symposium on advanced treatments in neovascular retinal disease.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLsKamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.
Latest:
EnVision Summit 2025: Complications in glaucoma surgeryAt the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.
Latest:
The eyes offer conjunctival clue to COVID-19A patient's vision loss leads to another diagnosis
Latest:
50 years of ophthalmology: What changed the game (Part 1)In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
Latest:
From waste to wonder: Transformational advances in scleral allograft technologyUnlocking the potential of donor scleral tissue: Innovations and future applications.
Latest:
Subretinal drusenoid deposits: Marker for unrecognized cardiac diseaseNew research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need for ophthalmologists to screen patients effectively.
Latest:
Dilsher S. Dhoot, MD, FASRS, on the landscape of geographic atrophy therapyA look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive retinal disease.
Latest:
EyeCon 2024: Key takeaways for enhanced patient care from Day 1Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.
Latest:
Driving practice growth: Expand on link between dry eye, aestheticsOne obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Latest:
Ocular surface health and IOL choicesEnhanced monofocal technology may benefit patients with cataracts and dry eye.
Latest:
Mercy Ships delivers a lifeline for eye health in Africa’s remote communitiesThrough its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
Latest:
Q&A: Baruch D. Kuppermann, MD, PhD, on the latest in retinaThe Retina World Congress showcases global innovations in surgical and medical retina, highlighting emerging treatments and fostering collaboration among specialists.
Latest:
Protection of eyes during prone positioning must be routinely monitored in ICUTreatment of patients with COVID-19 should include ophthalmic considerations.
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Latest:
Neuropathic dry eye: When serum defeats tearsOphthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Latest:
Neuropathic dry eye: When serum defeats tearsOphthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
